Cooperative Agreement U48DP006957
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $350K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Tucson, AZ, USA
Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC), through the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), awarded a $449,998 Cooperative Agreement to the University of Pennsylvania to support the "PRAGMATIC IMPLEMENTATION OF STRATEGIC INTERVENTIONS TO IMPROVE INITIATION OF MOUD WITHIN EMERGENCY DEPARTMENTS." The project aims to develop and implement effective practices for preventing injuries and violence, with a focus on...
- This Cooperative Agreement award for $348,837 was granted by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The award supports research by The General Hospital Corporation (Massachusetts General Hospital) on the effects of high-dose medications for opioid use disorder on treatment retention, drug use patterns, and overdose risks amidst the...
- This federal Cooperative Agreement award of $349,997, provided by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), supports the Regents of the University of Minnesota's efforts to expand access to low-barrier buprenorphine in acute care settings. The project aims to enhance best practice model fidelity and implement prehospital innovations to...
- This Cooperative Agreement award, CE25-149, was provided by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $349,258 grant was awarded to the University of North Carolina at Chapel Hill (UNC-CH) on September 30, 2025 for a project period ending on September 29, 2028. The grant will fund research on the effect of Medicaid expansion on medications for opioid use disorder, mental health care, and...
- This Cooperative Agreement award, totaling $341,020.00, was provided by the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) to evaluate the impact of a publicly funded partial hospitalization program in reducing overdose risk in Philadelphia. The award was made to the Public Health Management Corporation (PHMC), a non-profit health and social service organization based in Philadelphia. The project period...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) provides $699,911 in funding to The Johns Hopkins University to conduct a Randomized Clinical Trial of a Peer Education Intervention to Promote Social Diffusion of Overdose Prevention and Drug Use Cessation in High Burden Communities. The project period is from Sep 30, 2025 to Sep 29, 2030. The goal of the research is...
- The Centers for Disease Control and Prevention (CDC) awarded a $350,000 Cooperative Agreement under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) to King County, doing business as Public Health-Seattle & King County, to conduct a rigorous evaluation of community-delivered short- and long-acting buprenorphine treatments for people experiencing homelessness or living in permanent supportive housing. The award, effective September 30, 2025,...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $699,083 Cooperative Agreement to Purdue University on September 30, 2025 under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) federal grant program. The ED-SMART project aims to develop, implement, and evaluate substance use screening, motivational interviewing, and active referral interventions in emergency department settings to prevent substance use disorder and overdose....
- This Cooperative Agreement, awarded by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,664,000.00 in funding to The Washington University to develop negative allosteric modulators (NAMs) of the mu opioid receptor as potential treatments for opioid overdose and opioid use disorder. The key products and services to be delivered through this 2-year award, which runs from September 1, 2025 to August 31, 2027, include...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...